Fortress Biotech Inc FBIO:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 03/28/24 EDT
2.00UNCH (UNCH)
Volume
309,040
52 week range
1.24 - 12.75
Loading...
  • Open2.16
  • Day High2.17
  • Day Low1.97
  • Prev Close2.17
  • 52 Week High12.75
  • 52 Week High Date04/14/23
  • 52 Week Low1.24
  • 52 Week Low Date11/10/23

Key Stats

  • Market Cap36.754M
  • Shares Out18.38M
  • 10 Day Average Volume0.35M
  • Dividend-
  • Dividend Yield-
  • Beta1.52
  • YTD % Change-33.55

KEY STATS

  • Open2.16
  • Day High2.17
  • Day Low1.97
  • Prev Close2.17
  • 52 Week High12.75
  • 52 Week High Date04/14/23
  • 52 Week Low1.24
  • 52 Week Low Date11/10/23
  • Market Cap36.754M
  • Shares Out18.38M
  • 10 Day Average Volume0.35M
  • Dividend-
  • Dividend Yield-
  • Beta1.52
  • YTD % Change-33.55

RATIOS/PROFITABILITY

  • EPS (TTM)-56.59
  • P/E (TTM)-0.04
  • Fwd P/E (NTM)-0.35
  • EBITDA (TTM)-167.175M
  • ROE (TTM)-215.30%
  • Revenue (TTM)80.971M
  • Gross Margin (TTM)64.97%
  • Net Margin (TTM)-225.53%
  • Debt To Equity (MRQ)292.62%

EVENTS

  • Earnings Date03/28/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Fortress Biotech Inc

 

Profile

MORE
Fortress Biotech, Inc. is a biopharmaceutical company that acquires, develops and commercializes pharmaceutical and biotechnology products and product candidates. The Company markets its various branded dermatology products, Qbrexza, Accutane, Amzeeq, Zilxi, Ximino, Exelderm and Targadox. Qbrexza (glycopyrronium 2.4%) is a medicated cloth towelette for the treatment of primary axillary hyperhidrosis in adults and children nine years and older. Accutane (isotretinoin) is an...
Lindsay Rosenwald M.D.
Executive Chairman of the Board, President, Chief Executive Officer
Eric Rowinsky M.D.
Co-Vice Chairman of the Board
David Jin
Chief Financial Officer, Corporate Secretary
Address
1111 KANE CONCOURSE, SUITE 301
Bay Harbor Islands, FL
33154
United States

Top Peers

SYMBOLLASTCHG%CHG
SABS
SAB Biotherapeutics Inc
4.54UNCHUNCH
PRE
Prenetics Global Ltd
4.05UNCHUNCH
HLTH
Cue Health Inc
0.1886UNCHUNCH
PSNL
Personalis Inc
1.49UNCHUNCH
CDTX
Cidara Therapeutics Inc
0.92UNCHUNCH